Shut Up, They Explained (to Ezetimibe Critics)

Courtesy Health Care Renewal  Fri, 08/01/2008 - 13:33

One of our scouts alerted me to a remarkable editorial just published by Harrison, Brown and Raggi on the ezetimibe controversy [Harrison DG, Brown WV, Raggi P.

Enhanced hype. Am J Cardiol 2008; 102: 368-369. Link here , requires subscription.]

We have posted before (as have many others,) about problems with the ENHANCE trial of ezetimibe (Zetia , by Schering-Plough , and one component of Vytorin , by Merck ), and how...


 

More related items

New CABG, PCI Guidelines Stress Collaboration (CME/CE)
(MedPage Today) -- New guidelines, the result of a first-time collaboration between the American College of Cardiology and the American Heart Association, stress a multidisciplinary approach...

ACC/AHA Say Don't Start Beta-Blockers on Day of...
High-risk patients who are not taking beta-blockers should have beta-blocker therapy started well before scheduled cardiovascular surgery, with doses titrated up as the surgery date...

This week in medicine
The following will appear in the Nov 22 issue of The Lancet: Clinical guidelines The American College of Cardiology and American Heart Association have released the first guidelines for the...

The Unwritten Rules of Friendship: Simple Strategies...
"Nobody likes me!" is a complaint that parents hear all too often, and few utterances make them feel more helpless. Now help is at hand: This practical and compassionate guidebook enables...

Burt's Bees Free Head to Toe Starter Kit


 

Post new comment

The content of this field is kept private and will not be shown publicly.
health-fitness.marc8.com